EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Prepartum bumetanide treatment reverses altered neonatal social communication but nonspecifically reduces postpubertal social behavior in a mouse model of fragile X syndrome

Yui Sakamoto iD, Takeshi Takano iD, Shuji Shimoyama iD, Takeshi Hiramoto iD, Noboru Hiroi iD, Kazuhiko Nakamura iD

Genomic Psychiatry · 2024

DOI: 10.61373/gp024h.0094 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genomic Psychiatry, 2024. Verfasst von Yui Sakamoto und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuropsychiatry, Hirosaki University Graduate School of Medicine, Hirosaki, Aomori, Japan 036-8562. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIDCD NIH HHS, NIMH NIH HHS, NICHD NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Fragile X syndrome is caused by monogenic silencing of the FMR1 gene and is characterized by high rates of autism spectrum disorder. A previous study demonstrated that prepartum administration of bumetanide, a chloride transporter blocker, normalized neonatal vocalization in non-congenic Fmr1 knockout (KO) pups. However, the genuine contribution of Fmr1 deletion to this phenotype in a congenic Fmr1 KO mouse model and the long-lasting effect of prepartum bumetanide administration on postpubertal social interaction remains unclear. The current study aimed to determine the impact of prepartum bumetanide administration on vocalization at postnatal day 7 and social interaction at 6 and 8 weeks of age in a congenic Fmr1 KO mouse model in which the genetic backgrounds were homogeneous between KO and wild-type (WT) littermates. Moreover, we applied a computational analytical algorithm and determined predictive variables of neonatal vocalization for postpubertal social interaction. Our data showed that (1) KO mice exhibited altered numbers and sequences of distinct call types during neonatal vocalization and reduced social interaction at 6 weeks, (2) select sets of neonatal vocalization variables predicted postpubertal social interaction levels, and (3) bumetanide restored neonatal vocalization in KO pups but nonspecifically reduced social interaction in WT and KO mice at 6 weeks. These data indicate that Fmr1 deletion selectively impacts distinct elements of neonatal vocalization and postpubertal social interaction. Additionally, bumetanide selectively restores neonatal vocalization but has a transient nonspecific negative impact on subsequent postpubertal social interaction.

Schlagwörter

Stichwörter der Autor:innen

FMRPFmr1Fragile XGABAcritical periodmachine learningpredictorssocial communicationsocial interaction

Autor:innen und Institutionen

  • Department of Neuropsychiatry, Hirosaki University Graduate School of Medicine, Hirosaki, Aomori, Japan 036-8562.
  • Department of Pharmacology, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA 78229.
  • Tokyo Denki University, Ishizuka, Hatoyama-machi, Hiki-gun, Saitama 350-0394, Japan.
  • Department of Neurophysiology, Hirosaki University Graduate School of Medicine, Hirosaki, Aomori, Japan 036-8562.
  • Department of Cellular and Integrative Physiology, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA 78229.
  • Department of Cell Systems Anatomy, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA 78229.

ORCID-Profile: Yui Sakamoto, Takeshi Takano, Shuji Shimoyama, Takeshi Hiramoto, Noboru Hiroi, Kazuhiko Nakamura

Förderung

  • NIDCD NIH HHS
  • NIMH NIH HHS
  • NICHD NIH HHS

Zitieren

APA

Sakamoto, Y., Takano, T., Shimoyama, S., Hiramoto, T., Hiroi, N., & Nakamura, K. (2024). Prepartum bumetanide treatment reverses altered neonatal social communication but nonspecifically reduces postpubertal social behavior in a mouse model of fragile X syndrome. Genomic Psychiatry. https://doi.org/10.61373/gp024h.0094

Vancouver

Sakamoto Y, Takano T, Shimoyama S, Hiramoto T, Hiroi N, Nakamura K. Prepartum bumetanide treatment reverses altered neonatal social communication but nonspecifically reduces postpubertal social behavior in a mouse model of fragile X syndrome. Genomic Psychiatry. 2024. doi:10.61373/gp024h.0094

BibTeX
@article{Sakamoto2024,
  author = {Sakamoto, Yui and Takano, Takeshi and Shimoyama, Shuji and Hiramoto, Takeshi and Hiroi, Noboru and Nakamura, Kazuhiko},
  title = {Prepartum bumetanide treatment reverses altered neonatal social communication but nonspecifically reduces postpubertal social behavior in a mouse model of fragile X syndrome},
  journal = {Genomic Psychiatry},
  year = {2024},
  doi = {10.61373/gp024h.0094}
}
Kostenlos starten →